Most Recent Links
Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.
by Simon Makin Talking in your sleep might be annoying, but listening may yet prove useful. Researchers have shown that sleeping brains not only recognise words, but can also categorise them and respond in a previously defined way. This could one day help us learn more efficiently. Sleep appears to render most of us dead to the world, our senses temporarily suspended, but sleep researchers know this is a misleading impression. For instance, a study published in 2012 showed that sleeping people can learn to associate specific sounds and smells. Other work has demonstrated that presenting sounds or smells during sleep boosts performance on memory tasks – providing the sensory cues were also present during the initial learning. Now it seems the capabilities of sleeping brains stretch even further. A team led by Sid Kouider from the Ecole Normale Supérieur in Paris trained 18 volunteers to classify spoken words as either animal or object by pressing buttons with their right or left hand. Brain activity was recorded using EEG, allowing the researchers to measure the telltale spikes in activity that indicate the volunteers were preparing to move one of their hands. Since each hand is controlled by the motor cortex on the opposite side of the brain, these brainwaves can be matched to the intended hand just by looking at which side of the motor cortex is active. © Copyright Reed Business Information Ltd.
David Cyranoski A Japanese patient with a debilitating eye disease is about to become the first person to be treated with induced pluripotent stem cells, which have generated enthusiastic expectations and earned their inventor a Nobel Prize. A health-ministry committee has vetted researchers' safety tests and cleared the team to begin the experimental procedure. Masayo Takahashi, an ophthalmologist at the RIKEN Center for Developmental Biology (CDB) in Kobe, has been using induced pluripotent stem (iPS) cells to prepare a treatment for age-related macular degeneration. Unlike embryonic stem cells, iPS cells are produced from adult cells, so they can be genetically tailored to each recipient. They are capable of becoming any cell type in the body, and have the potential to treat a wide range of diseases. The CDB trial will be the first opportunity for the technology to prove its clinical value. In age-related macular degeneration, extra blood vessels form in the eye, destabilizing a supportive base layer of the retina known as the retinal pigment epithelium. This results in the loss of the light-sensitive photoreceptors that are anchored in the epithelium, and often leads to blindness. Takahashi took skin cells from people with the disease and converted them to iPS cells. She then coaxed these cells to become retinal pigment epithelium cells, and then to grow into thin sheets that can be transplanted to the damaged retina. Takahashi and her collaborators have shown in monkey studies1 that iPS cells generated from the recipients' own cells do not provoke an immune reaction that causes them to be rejected. There have been concerns that iPS cells could cause tumours, but Takahashi's team has found that to be unlikely in mice2 and monkeys1. © 2014 Nature Publishing Group
Corie Lok Tami Morehouse's vision was not great as a child, but as a teenager she noticed it slipping even further. The words she was trying to read began disappearing into the page and eventually everything faded to a dull, grey haze. The culprit was a form of Leber's congenital amaurosis (LCA), a group of genetic disorders in which light-sensing cells in the retina die off, usually resulting in total blindness by the time people reach their thirties or forties. But Morehouse got a reprieve. In 2009, at the age of 44, the social worker from Ashtabula, Ohio, became the oldest participant in a ground-breaking clinical trial to test a gene therapy for LCA. Now, she says, she can see her children's eyes, and the colours of the sunset seem brighter than before. Morehouse calls these improvements life-changing, but they are minor compared with the changes in some of the younger trial participants. Corey Haas was eight years old when he was treated in 2008 — the youngest person to receive the therapy. He went from using a white cane to riding a bicycle and playing softball. Morehouse often wonders what she would be able to see now if she had been closer to Haas's age when she had the therapy. “I was born a little too soon,” she says. Visual impairment affects some 285 million people worldwide, about 39 million of whom are considered blind, according to a 2010 estimate from the World Health Organization. Roughly 80% of visual impairment is preventable or curable, including operable conditions such as cataracts that account for much of the blindness in the developing world. But retinal-degeneration disorders — including age-related macular degeneration, the leading cause of blindness in the developed world — have no cure. © 2014 Nature Publishing Group
Link ID: 20064 - Posted: 09.11.2014
By JOSHUA A. KRISCH PHILADELPHIA — McBaine, a bouncy black and white springer spaniel, perks up and begins his hunt at the Penn Vet Working Dog Center. His nose skims 12 tiny arms that protrude from the edges of a table-size wheel, each holding samples of blood plasma, only one of which is spiked with a drop of cancerous tissue. The dog makes one focused revolution around the wheel before halting, steely-eyed and confident, in front of sample No. 11. A trainer tosses him his reward, a tennis ball, which he giddily chases around the room, sliding across the floor and bumping into walls like a clumsy puppy. McBaine is one of four highly trained cancer detection dogs at the center, which trains purebreds to put their superior sense of smell to work in search of the early signs of ovarian cancer. Now, Penn Vet, part of the University of Pennsylvania’s School of Veterinary Medicine, is teaming with the university’s chemistry and physics departments to isolate cancer chemicals that only dogs can smell. They hope this will lead to the manufacture of nanotechnology sensors that are capable of detecting bits of cancerous tissue 1/100,000th the thickness of a sheet of paper. “We don’t ever anticipate our dogs walking through a clinic,” said the veterinarian Dr. Cindy Otto, the founder and executive director of the Working Dog Center. “But we do hope that they will help refine chemical and nanosensing techniques for cancer detection.” Since 2004, research has begun to accumulate suggesting that dogs may be able to smell the subtle chemical differences between healthy and cancerous tissue, including bladder cancer, melanoma and cancers of the lung, breast and prostate. But scientists debate whether the research will result in useful medical applications. © 2014 The New York Times Company
Keyword: Chemical Senses (Smell & Taste)
Link ID: 20063 - Posted: 09.11.2014
By Helen Briggs Health editor, BBC News website There may be a link between a rare blood type and memory loss in later life, American research suggests. People with AB blood, found in 4% of the population, appear more likely to develop thinking and memory problems than those with other blood groups. The study, published in Neurology, builds on previous research showing blood type may influence heart risk. A charity said the best way to keep the brain healthy was a balanced diet, regular exercise and not smoking. A US team led by Dr Mary Cushman, of the University of Vermont College of Medicine, Burlington, analysed data from about 30,000 US citizens aged 45 and above. It identified 495 participants who had developed thinking and memory problems, or cognitive impairment, during the three-year study. They were compared to 587 people with no cognitive problems. People with AB blood type made up 6% of the group who developed cognitive impairment, which is higher than the 4% found in the general population. They were 82% more likely to have difficulties with day-to-day memory, language and attention, which can signal the onset of dementia. However, the study did not look at the risk of dementia. The study supported the idea that having a certain blood group, such as O, may give a lower risk for cardiovascular disease, which in turn protected the brain, the researchers said. "Our study looks at blood type and risk of cognitive impairment, but several studies have shown that factors such as high blood pressure, high cholesterol and diabetes increase the risk of cognitive impairment and dementia," said Dr Cushman. BBC © 2014
By Sarah Zielinski The marshmallow test is pretty simple: Give a child a treat, such as a marshmallow, and promise that if he doesn’t eat it right away, he’ll soon be rewarded with a second one. The experiment was devised by Stanford psychologist Walter Mischel in the late 1960s as a measure of self-control. When he later checked back in with kids he had tested as preschoolers, those who had been able to wait for the second treat appeared to be doing better in life. They tended to have fewer behavioral or drug-abuse problems, for example, than those who had given in to temptation. Most attempts to perform this experiment on animals haven’t worked out so well. Many animals haven’t been willing to wait at all. Dogs, primates, and some birds have done a bit better, managing to wait at least a couple of minutes before eating the first treat. The best any animal has managed has been 10 minutes—a record set earlier this year by a couple of crows. The African grey parrot is a species known for its intelligence. Animal psychologist Irene Pepperberg, now at Harvard, spent 30 years studying one of these parrots, Alex, and showed that the bird had an extraordinary vocabulary and capacity for learning. Alex even learned to add numerals before his death in 2007. Could an African grey pass the marshmallow test? Adrienne E. Koepke of Hunter College and Suzanne L. Gray of Harvard University tried the experiment on Pepperberg’s current star African grey, a 19-year-old named Griffin. In their test, a researcher took two treats, one of which Griffin liked slightly better, and put them into cups. Then she placed the cup with the less preferred food in front of Griffin and told him, “wait.” She took the other cup and either stood a few feet away or left the room. After a random amount of time, from 10 seconds to 15 minutes, she would return. If the food was still in the cup, Griffin got the nut he was waiting for. Koepke and colleagues presented their findings last month at the Animal Behavior Society meeting at Princeton. © 2014 The Slate Group LLC.
|By Amy Nordrum If you were one of millions of children who completed the Drug Abuse Resistance Education program, or D.A.R.E., between 1983 and 2009, you may be surprised to learn that scientists have repeatedly shown that the program did not work. Despite being the nation’s most popular substance-abuse prevention program, D.A.R.E. did not make you less likely to become a drug addict or even to refuse that first beer from your friends. But over the past few years prevention scientists have helped D.A.R.E. America, the nonprofit organization that administers the program, replace the old curriculum with a course based on a few concepts that should make the training more effective for today’s students. The new course, called keepin’ it REAL, differs in both form and content from the former D.A.R.E.—replacing long, drug-fact laden lectures with interactive lessons that present stories meant to help kids make smart decisions. Beginning in 2009 D.A.R.E. administrators required middle schools across the country that teach the program to switch over to the 10-week, researcher-designed curriculum for seventh graders. By 2013, they had ordered elementary schools to start teaching a version of those lessons to fifth and sixth graders, too. "It's not an antidrug program," says Michelle Miller-Day, co-developer of the new curriculum and a communications researcher at Chapman University. “It's about things like being honest and safe and responsible." Even so, keepin’ it REAL has reduced substance abuse and maintained antidrug attitudes over time among students in early trials—an achievement that largely eluded the former iteration of the program. D.A.R.E.’s original curriculum was not shaped by prevention specialists but by police officers and teachers in Los Angeles. They started D.A.R.E. in 1983 to curb the use of drugs, alcohol and tobacco among teens and to improve community–police relations. Fueled by word of mouth, the program quickly spread to 75 percent of U.S. schools. © 2014 Scientific American,
Keyword: Drug Abuse
Link ID: 20060 - Posted: 09.11.2014
By Lesley Evans Ogden Humans are noisy creatures, our cacophony of jet engines and jackhammering drowning out the communications of other species. In response, a number of animals, including marmosets and whales, turn up their own volume to be heard above the din, a phenomenon called the Lombard effect. A new study reveals that even fish “shout.” Researchers took a close look at the blacktail shiner (Cyprinella venusta), which is common to freshwater streams of the southeastern United States and whose short-distance acoustic signals are often exposed to boat and road noise. Only male shiners make sounds; popping sounds called knocks are used aggressively toward other males, while staticky-sounding “growls” are used for courtship, both heard in the above video. When the scientists brought the fish back to the lab and cranked up white noise from an underwater amplifier, they found that shiner males emitted fewer, shorter pulses, and cranked up the volume of their acoustic signals to be heard above background noise. Published in Behavioral Ecology, it’s the first study documenting the Lombard effect in fish, suggesting that freshwater fish are another group potentially impacted by our ever-increasing hubbub. © 2014 American Association for the Advancement of Science
Ian Sample, science editor Heartbreak can impair the immune system of older people and make them more prone to infections, researchers have found. Scientists said older people who had suffered a recent bereavement had poorer defences against bacteria, which could leave them more vulnerable to killer infections, such as pneumonia. Blood tests showed that the same group had imbalances in their stress hormones, which are known to have a direct impact on the body's ability to fight off bugs. Anna Phillips, a reader in behavioural medicine at Birmingham University, said the damaging effects of bereavement on the immune system were not seen in younger people, whose defences seemed more resilient. The finding suggests that in the weeks and months after the loss of a loved one, older people should keep in touch with their friends and family, and exercise and eat well, to reduce stress levels and boost their immune systems. "Bereavement is a really key stressor that happens to all of us at some point so it's worth being aware of the negative impact it can have on your health," Phillips said. "It's a key time to look after yourself in terms of your psychological and physical wellbeing. Don't try and cope by staying in, drinking more and exercising less. Try to cope by having social interactions, looking after yourself by keeping a certain level of fitness and eating well," she added. For her study, Phillips recruited people who had lost a loved one, either a spouse or family member, in the past two months. She then looked at how well bacteria-killing immune cells called neutrophils performed. © 2014 Guardian News and Media Limited
By Helen Briggs Health editor, BBC News website Long-term use of pills for anxiety and sleep problems may be linked to Alzheimer's, research suggests. A study of older Canadian adults found that past benzodiazepine use for three months or more was linked to an increased risk (up to 51%) of dementia. NHS guidelines say the drugs should be used for eight to 12 weeks at most. The French-Canadian team says while the link is not definitive, it is another warning that treatments should not exceed three months. "Benzodiazepine use is associated with an increased risk of Alzheimer's disease," lead researcher, Sophie Billioti de Gage of the University of Bordeaux, France, and colleagues wrote in the BMJ. "Unwarranted long-term use of these drugs should be considered as a public health concern." The study involved about 2,000 cases of Alzheimer's disease in adults aged over 66 living in Quebec. All had been prescribed benzodiazepines. They were compared with about 7,000 healthy people of the same age living in the same community. While an increased risk was found in those on benzodiazepines, the nature of the link was unclear. Dr Eric Karran, director of research at Alzheimer's Research UK, said: "This study shows an apparent link between the use of benzodiazepines and Alzheimer's disease although it's hard to know the underlying reason behind the link. BBC © 2014
By GARY GUTTING Sam Harris is a neuroscientist and prominent “new atheist,” who along with others like Richard Dawkins, Daniel Dennett and Christopher Hitchens helped put criticism of religion at the forefront of public debate in recent years. In two previous books, “The End of Faith” and “Letter to a Christian Nation,” Harris argued that theistic religion has no place in a world of science. In his latest book, “Waking Up,” his thought takes a new direction. While still rejecting theism, Harris nonetheless makes a case for the value of “spirituality,” which he bases on his experiences in meditation. I interviewed him recently about the book and some of the arguments he makes in it. Gary Gutting: A common basis for atheism is naturalism — the view that only science can give a reliable account of what’s in the world. But in “Waking Up” you say that consciousness resists scientific description, which seems to imply that it’s a reality beyond the grasp of science. Have you moved away from an atheistic view? Sam Harris: I don’t actually argue that consciousness is “a reality” beyond the grasp of science. I just think that it is conceptually irreducible — that is, I don’t think we can fully understand it in terms of unconscious information processing. Consciousness is “subjective”— not in the pejorative sense of being unscientific, biased or merely personal, but in the sense that it is intrinsically first-person, experiential and qualitative. The only thing in this universe that suggests the reality of consciousness is consciousness itself. Many philosophers have made this argument in one way or another — Thomas Nagel, John Searle, David Chalmers. And while I don’t agree with everything they say about consciousness, I agree with them on this point. © 2014 The New York Times Company
Link ID: 20056 - Posted: 09.10.2014
By Smitha Mundasad Health reporter, BBC News More than 300 people a year in the UK and Ireland report they have been conscious during surgery - despite being given general anaesthesia. In the largest study of its kind, scientists suggests this happens in one in every 19,000 operations. They found episodes were more likely when women were given general anaesthesia for Caesarean sections or patients were given certain drugs. Experts say though rare, much more needs to be done to prevent such cases. Led by the Royal College of Anaesthetists and Association of Anaesthetists of Great Britain and Ireland, researchers studied three million operations over a period of one year. More than 300 people reported they had experienced some level of awareness during surgery. Most episodes were short-lived and occurred before surgery started or after operations were completed. But some 41% of cases resulted in long-term psychological harm. Patients described a variety of experiences - from panic and pain to choking - though not all episodes caused concern. The most alarming were feelings of paralysis and being unable to communicate, the researchers say. One patient, who wishes to remain anonymous, described her experiences of routine orthodontic surgery at the age of 12. She said: "I could hear voices around me and I realised with horror that I had woken up in the middle of the operation but couldn't move a muscle. BBC © 2014
People who are obese may be more susceptible to environmental food cues than their lean counterparts due to differences in brain chemistry that make eating more habitual and less rewarding, according to a National Institutes of Health study published in Molecular Psychiatry External Web Site Policy. Researchers at the NIH Clinical Center found that, when examining 43 men and women with varying amounts of body fat, obese participants tended to have greater dopamine activity in the habit-forming region of the brain than lean counterparts, and less activity in the region controlling reward. Those differences could potentially make the obese people more drawn to overeat in response to food triggers and simultaneously making food less rewarding to them. A chemical messenger in the brain, dopamine influences reward, motivation and habit formation. “While we cannot say whether obesity is a cause or an effect of these patterns of dopamine activity, eating based on unconscious habits rather than conscious choices could make it harder to achieve and maintain a healthy weight, especially when appetizing food cues are practically everywhere,” said Kevin D. Hall, Ph.D., lead author and a senior investigator at National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of NIH. “This means that triggers such as the smell of popcorn at a movie theater or a commercial for a favorite food may have a stronger pull for an obese person — and a stronger reaction from their brain chemistry — than for a lean person exposed to the same trigger.” Study participants followed the same eating, sleeping and activity schedule. Tendency to overeat in response to triggers in the environment was determined from a detailed questionnaire. Positron emission tomography (PET) scans evaluated the sites in the brain where dopamine was able to act.
|By Gary Stix A biochemical produced in the brain called oxytocin has entered popular culture in recent years as the “love,” “cuddle” or “bonding” hormone. That’s a lot to choose from. Oxytocin plays a role in producing contractions at childbirth and in helping in lactation, but we’ve known that for more than a century. Experiments in the 1990s showed that it was instrumental in leading prairie voles, known for their monogamous behavior, to pick a lifelong mate. Later studies then demonstrated that the chemical contributes to trust and social interactions in various animals, including humans. After the vole study, interest in the nine–amino acid peptide started to rise. In a TED talk economist Paul Zak called it “the moral molecule” because of its link to trust, empathy and prosperity. The Internet DIY brain-makeover market then took up the meme. Vero Labs of Daytona Beach, Fla., sells “Connekt” oxytocin spray for $79 that purports to “strengthen workplace bonds” and “increase positive self-awareness.” The company has also come out with a his-and-her“Attrakt” spray that mixes oxytocin with pheromones—chemical sex attractants that help mice get it on, but whose role in triggering mating behavior in humans is hotly disputed. (Researchers who study oxytocin warn prospective buyers away from these purchases, saying that long-term use in humans has not been studied.) © 2014 Scientific American
By SOMINI SENGUPTA A coalition of political figures from around the world, including Kofi Annan, the former United Nations secretary general, and several former European and Latin American presidents, is urging governments to decriminalize a variety of illegal drugs and set up regulated drug markets within their own countries. The proposal by the group, the Global Commission on Drug Policy, goes beyond its previous call to abandon the nearly half-century-old American-led war on drugs. As part of a report scheduled to be released on Tuesday, the group goes much further than its 2011 recommendation to legalize cannabis. The former Brazilian president Fernando Henrique Cardoso, a member of the commission, said the group was calling for the legal regulation of “as many of the drugs that are currently illegal as possible, with the understanding that some drugs may remain too dangerous to decriminalize.” The proposal comes at a time when several countries pummeled by drug violence, particularly in Latin America, are rewriting their own drug laws, and when even the United States is allowing state legislatures to gingerly regulate cannabis use. The United Nations is scheduled to hold a summit meeting in 2016 to evaluate global drug laws. The commission includes former presidents like Mr. Cardoso of Brazil, Ernesto Zedillo of Mexico and Ruth Dreifuss of Switzerland, along with George P. Shultz, a former secretary of state in the Reagan administration, among others. The group stops short of calling on countries to legalize all drugs right away. It calls instead for countries to continue to pursue violent criminal gangs, to stop incarcerating users and to offer treatment for addicts. © 2014 The New York Times Company
Keyword: Drug Abuse
Link ID: 20052 - Posted: 09.10.2014
By Mo Costandi The nerve endings in your fingertips can perform complex neural computations that were thought to be carried out by the brain, according to new research published in the journal Nature Neuroscience. The processing of both touch and visual information involves computations that extract the geometrical features of objects we touch and see, such as the edge orientation. Most of this processing takes place in the brain, which contains cells that are sensitive to the orientation of edges on the things we touch and see, and which pass this information onto cells in neighbouring regions, that encode other features. The brain has outsourced some aspects of visual processing, such as motion detection, to the retina, and the new research shows that something similar happens in the touch processing pathway. Delegating basic functions to the sense organs in this way could be an evolutionary mechanism that enables the brain to perform other, more sophisticated information processing tasks more efficiently. Your fingertips are among the most sensitive parts of your body. They are densely packed with thousands of nerve endings, which produce complex patterns of nervous impulses that convey information about the size, shape and texture of objects, and your ability to identify objects by touch and manipulate them depends upon the continuous influx of this information. © 2014 Guardian News and Media Limited
Keyword: Pain & Touch
Link ID: 20051 - Posted: 09.09.2014
Ewen Callaway Researchers found 69 genes that correlate with higher educational attainment — and three of those also also appear to have a direct link to slightly better cognitive abilities. Scientists looking for the genes underlying intelligence are in for a slog. One of the largest, most rigorous genetic study of human cognition1 has turned up inconclusive findings, and experts concede that they will probably need to scour the genomes of more than 1 million people to confidently identify even a small genetic influence on intelligence and other behavioural traits. Studies of twins have repeatedly confirmed a genetic basis for intelligence, personality and other aspects of behaviour. But efforts to link IQ to specific variations in DNA have led to a slew of irreproducible results. Critics have alleged that some of these studies' methods were marred by wishful thinking and shoddy statistics. A sobering editorial in the January 2012 issue of Behavior Genetics2 declared that “it now seems likely that many of the published findings of the last decade are wrong or misleading and have not contributed to real advances in knowledge”. In 2011, an international collaboration of researchers launched an effort to bring more rigour to studies of how genes contribute to behaviour. The group, called the Social Sciences Genetic Association Consortium, aimed to do studies using practices borrowed from the medical genetics community, which emphasizes large numbers of participants, rigorous statistics and reproducibility. In a 2013 study3 comparing the genomes of more than 126,000 people, the group identified three gene variants associated with with how many years of schooling a person had gone through or whether they had attended university. But the effect of these variants was small — each variant correlated with roughly one additional month of schooling in people who had it compared with people who did not. © 2014 Nature Publishing Group
By Jena McGregor We've all heard the conventional wisdom for better managing our time and organizing our professional and personal lives. Don't try to multitask. Turn the email and Facebook alerts off to help stay focused. Make separate to-do lists for tasks that require a few minutes, a few hours and long-term planning. But what's grounded in real evidence and what's not? In his new book The Organized Mind, Daniel Levitin — a McGill University professor of psychology and behavioral neuroscience — explores how having a basic understanding of the way the brain works can help us think about organizing our homes, our businesses, our time and even our schools in an age of information overload. We spoke with Levitin about why multi-tasking never works, what images of good leaders' brains actually look like, and why email and Twitter are so incredibly addicting. The following transcript of our conversation has been edited for length and clarity. Q. What was your goal in writing this book? A. Neuroscientists have learned a lot in the last 10 or 15 years about how the brain organizes information, and why we pay attention to some things and forget others. But most of this information hasn't trickled down to the average reader. There are a lot of books about how to get organized and a lot of books about how to be better and more productive at business, but I don't know of one that grounds any of these in the science.
Link ID: 20049 - Posted: 09.09.2014
By C. CLAIBORNE RAY Q. Is there a difference between alcoholic dementia and “regular” dementia in the elderly? A. Dementia refers to the general category of diseases that cause acquired cognitive loss, usually in later life, said Dr. Mark S. Lachs, director of geriatrics for the NewYork-Presbyterian Healthcare System. Such loss has scores of possible causes, he said, but Alzheimer’s disease is the culprit in a vast majority of cases in the developed world. Alzheimer’s and what doctors call alcohol-related dementia affect parts of the brain cortex that control memory, language and the ability to follow motor commands. Because Alzheimer’s and excessive drinking are relatively common in the older population and can occur at the same time, and because many of their clinical features overlap and affect similar parts of the brain, “it is more accurate to say that each condition potentially exacerbates the other,” Dr. Lachs said. Abstinence is the treatment of choice in alcohol-related dementia, with or without concurrent Alzheimer’s disease or another form of dementia. Even in patients with “pure” Alzheimer’s disease or another kind of dementia, Dr. Lachs said, most experts recommend greatly moderating alcohol consumption or eliminating it, as even occasional drinking “can serve as a brain stress test for a patient with impaired cognition from any cause.” © 2014 The New York Times Company
By Maggie Fox, Erika Edwards and Judy Silverman Here’s how you might be able to turn autism around in a baby: Carefully watch her cues, and push just a little harder with that game of peek-a-boo or “This little piggy.” But don’t push too hard — kids with autism are super-sensitive. That’s what Sally Rogers of the University of California, Davis has found in an intense experiment with the parents of infants who showed clear signs of autism. It’s one of the most hopeful signs yet that if you diagnose autism very early, you can help children rewire their brains and reverse the symptoms. It was a small study, and it’s very hard to find infants who are likely to have autism, which is usually diagnosed in the toddler years. But the findings, published in the Journal of Autism and Developmental Disorders, offer some hope to parents worried about their babies. “With only seven infants in the treatment group, no conclusions can be drawn,” they wrote. However, the effects were striking. Six out of the seven children in the study had normal learning and language skills by the time they were 2 to 3. Isobel was one of them. “She is 3 years old now and she is a 100 percent typical, normally developing child,” her mother, Megan, told NBC News. The family doesn’t want their last name used for privacy reasons. “We don’t have to do the therapy any more. It literally rewired her brain.” Autism is a very common diagnosis for children in the U.S. The latest survey by the Centers for Disease Control and Prevention shows a startling 30 percent jump among 8-year-olds diagnosed with the disorder in a two-year period, to one in every 68 children.
Link ID: 20047 - Posted: 09.09.2014